What are the biological factors that contribute to weight gain
Drugs developed for the treatment of diabetes show protective effects in Alzheimers and Parkinsons diseases
Professional medical organizations are developing comprehensive obesity treatment guidelines that position pharmacotherapy as integral component of multimodal management strategies
GLP-1 medications can help manage type 2 diabetes and obesity, but they may cause short-term mild-to-moderate side effects such as nausea, vomiting, diarrhoea, constipation, bloating, and decreased appetite, particularly at the beginning of treatment
When rheumatologists use them for inflammatory arthritis, it is considered off-label prescribing a legal and common practice when supported by emerging clinical evidence and individualized patient need
A causal link between prediction errors, dopamine neurons and learning